Dextro-oxiracetam powder injection for injecting and preparation method thereof
A kind of technology of dextrooxypyramid powder and dextrooxypyramid, which is applied in the field of dextrooxypyramid preparations, and can solve the problems of high related substances, unstable quality, unfavorable clinical application and the like
Examples
Embodiment 1
[0017] Use n-propanol to dissolve the commercially available raw material of dextrooxypyridamide at a concentration of 25 mg / mL, cover and seal, stir at a temperature of 35 °C at a speed of 250 r / min for 15 h, filter, and let the filtrate stand for volatilization and crystallization, collect The crystals were dried for 5 hours at a temperature of 70°C and a relative humidity of 25% to obtain the dextrooxypyridamide crystalline compound.
[0018] Powder Diffraction Determination (XRPD): Test instrument conditions: use Bruker D2 PHASER powder diffractometer for room temperature test, test conditions: Cu Ka (1.5418 Å) as light source, voltage 30 kV, current 10 mA, test step size 0.014 o , scanning speed 0.1 s / step, scanning range 5-40 o (2θ). After testing, the X-ray powder diffraction spectrum of the dextrooxypyridamide crystalline compound prepared in Example 1 of the present invention represented by a diffraction angle of 2θ±0.2° is within 2 θ is 12.6±0.2°, 16.66±0.2°, 17.5...
Embodiment 2
[0020] Use n-propanol to dissolve the commercially available dextrooxypyridamide raw material at a concentration of 18 mg / mL, cover and seal, stir at a temperature of 20 °C at a speed of 300 r / min for 10 h, filter, and let the filtrate stand for volatilization and crystallization, collect The crystals were dried for 4 hours at a temperature of 60° C. and a relative humidity of 35% to obtain the dextrooxypyridamide crystalline compound. The determination method of Example 1 was used to detect that the dextrooxypyridine crystalline compound prepared in Example 2 was the same crystal form of dextrooxypyramide as in Example 1.
Embodiment 3
[0022] Use n-propanol to dissolve the commercially available raw material of dextrooxypyridamide at a concentration of 45 mg / mL, cover and seal, stir at a temperature of 45 °C at a speed of 100 r / min for 5 h, filter, and let the filtrate stand for volatilization and crystallization, collect The crystals were dried for 6 hours at a temperature of 75° C. and a relative humidity of 15% to obtain the dextrooxypyridamide crystalline compound. The detection method of Example 1 was used to detect that the dextrooxypyridine crystalline compound prepared in Example 3 was the same crystal form of dextrooxypyridine in Example 1.
PUM
Login to View More Abstract
Description
Claims
Application Information
- IPC
- A61K9/14; A61K47/18; A61K31/4015; A61P25/08; C07D207/273
- CPC
- A61K9/0019; A61K9/145; A61K31/4015; A61P25/08; C07B2200/07; C07B2200/13; C07D207/273
- Inventors
- 叶雷